|

LOXO-435 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LY3866288

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Ureteral Neoplasms1
  • Urinary Bladder Neoplasms1
  • Neoplasm Metastasis1
  • Cancer1

Tucson, Arizona1 trial

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

University of Arizona - Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.